BLCO Bausch + Lomb Corp.

Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2

3minutes ago

Bausch Health's Salix Pharmaceuticals Endorsed Implementation of ICD-10 Code From the Centers for Medicare & Medicaid Services (CMS) For Hepatic Encephalopathy

08:04 AM EDT, 10/03/2022 (MT Newswires) -- Bausch Health Companies Inc. (NYSE and TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals, one of the largest specialty pharmaceutical compan

10-03 20:07

Bausch + Lomb Introducing "Enhanced" Adult 50+ Eye Vitamin Formulation With Vitamin D

07:34 AM EDT, 10/03/2022 (MT Newswires) -- Bausch + Lomb Corp (BLCO.TO), an eye health company, on Monday announced the US introduction of enhanced Ocuvite Adult 50+ eye vitamin with 30 micrograms of

10-03 19:36

Bausch Health Announcing Final Results and Expiration of Exchange Offers and Consent Solicitations

08:56 AM EDT, 09/28/2022 (MT Newswires) -- Bausch Health Companies Inc. (BHC.TO) announced Wednesday the final results and expiration of its offers to exchange the existing senior notes for up to an a

09-28 20:58

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

07:36 AM EDT, 09/27/2022 (MT Newswires) -- Bausch + Lomb Corporation (BLCO.TO), an eye health company, on Tuesday announced the presentation of one podium and two poster presentations at the World Cor

09-27 19:38

Bausch + Lomb Brief: Says Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting

07:00 AM EDT, 09/26/2022 (MT Newswires) --

09-26 19:00

Bausch Health Brief: Bausch Health and Glenmark Announce the Approval of RYALTRIS in Canada

06:59 AM EDT, 09/23/2022 (MT Newswires) --

09-23 19:01

Global Ophthalmic Diagnostics Equipment Market to Surpass US$ 4,064.5 Million by 2030 - Coherent Market Insights

SEATTLE, Sept. 21, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global ophthalmic diagnostics equipment market is estimated to be valued at US$ 2,502.6 million in 2022 and is expe

09-22 02:40

HC Wainwright Begins Coverage on Bausch + Lomb (NYSE:BLCO)

HC Wainwright started coverage on shares of Bausch + Lomb (NYSE:BLCO – Get Rating) in a report released on Monday, MarketBeat.com reports. The brokerage issued a buy rating and a $21.00 price target

09-15 15:42

Bausch Health Details Early Exchange Offer Results for Exchange Offers and Consent Solicitations

09:09 AM EDT, 09/14/2022 (MT Newswires) -- Bausch Health Companies Inc. (NYSE and TSX: BHC) announced Wednesday the results to date of its previously announced offers to exchange existing senior notes

09-14 21:10